Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Cardiomyopathy | Research article

Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome

Authors: Yirao Tao, Jing Xu, Samira Yerima Bako, Xiaobo Yao, Donghui Yang

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Apical hypertrophic cardiomyopathy (ApHCM) is a phenotypic variant of nonobstructive HCM. ApHCM is characterized by left ventricular hypertrophy involve the distal apex. The electrocardiographic character of ApHCM can mimic non-ST elevation acute coronary syndrome (NSTEACS), triggering a series of studies and treatments that may be unnecessary. This study aimed to clarify the electrocardiogram (ECG) differences between the two diseases.

Methods

Initial ECG recordings of 41 patients with ApHCM and 72 patients with NSTEACS were analyzed retrospectively. We analyzed the voltage of negative T (neg T) and R wave, the change of ST-segment as well as the number of leads with neg T wave in the 12-lead ECGs.

Results

Across the 12-lead ECGs, the magnitude of R wave significantly differed between ApHCM and NSTEACS in 10 leads excluding leads aVR and V1. ApHCM was associated with a greater maximal amplitude of R wave in lead V5 (3.13 ± 1.08 vs. 1.38 ± 0.73 mV, P <  0.001). The magnitude of T wave significantly differed between ApHCM and NSTEACS in 10 leads excluding leads II and V1. ApHCM was associated with a greater maximal amplitude of neg T wave in lead V4 (0.85 ± 0.69 vs. 0.35 ± 0.23 mV, P <  0.001). The frequency of giant neg T (1mv or more) wave was higher in ApHCM (36.5% vs. 0%, P <  0.001). The magnitude of ST-segment deviation significantly differed between ApHCM and NSTEACS in 10 leads excluding leads aVF and V2. ApHCM was associated with a greater maximal amplitude of ST-segment depression in lead V5 (0.19 ± 0.07 vs. 0.03 ± 0.06 mV, P <  0.001). The number of leads with neg T wave also differed between ApHCM and NSTEACS (6.75 ± 1.42 vs. 6.08 ± 1.51, P = 0.046). The sum of R wave in lead V5, neg T wave in lead V6 and ST-segment depression in lead V4 > 2.585 mV identified ApHCM with 90.2% sensibility and 87.5% specificity, representing the highest diagnostic accuracy.

Conclusions

Compared with NSTEACS patients, ApHCM patients presented higher R and neg T wave voltage as well as a greater ST-segment depression in the 12-lead ECG. The ECG characteristics can help to differentiate ApHCM from NSTEACS in clinical setting.
Literature
1.
go back to reference Paluszkiewicz J, Krasinska B, Milting H, et al. Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment. Kardiochir Torakochirurgia Pol. 2018;15(4):246–53.PubMedPubMedCentral Paluszkiewicz J, Krasinska B, Milting H, et al. Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment. Kardiochir Torakochirurgia Pol. 2018;15(4):246–53.PubMedPubMedCentral
2.
go back to reference Jan MF, Todaro MC, Oreto L, et al. Apical hypertrophic cardiomyopathy: present status. Int J Cardiol. 2016;222:745–59.CrossRef Jan MF, Todaro MC, Oreto L, et al. Apical hypertrophic cardiomyopathy: present status. Int J Cardiol. 2016;222:745–59.CrossRef
3.
go back to reference Stephenson E, Monney P, Pugliese F, et al. Ineffective and prolonged apical contraction is associated with chest pain and ischaemia in apical hypertrophic cardiomyopathy. Int J Cardiol. 2018;251:65–70.CrossRef Stephenson E, Monney P, Pugliese F, et al. Ineffective and prolonged apical contraction is associated with chest pain and ischaemia in apical hypertrophic cardiomyopathy. Int J Cardiol. 2018;251:65–70.CrossRef
4.
go back to reference Malik LH, Singh GD, Amsterdam EA. T-wave tease: apical hypertrophic cardiomyopathy. Am J Med. 2014;127(6):498–500.CrossRef Malik LH, Singh GD, Amsterdam EA. T-wave tease: apical hypertrophic cardiomyopathy. Am J Med. 2014;127(6):498–500.CrossRef
5.
go back to reference Olearczyk B, Gollol-Raju N, Menzies DJ. Apical hypertrophic cardiomyopathy mimicking acute coronary syndrome: a case report and review of the literature. Angiology. 2008;59(5):629–31.CrossRef Olearczyk B, Gollol-Raju N, Menzies DJ. Apical hypertrophic cardiomyopathy mimicking acute coronary syndrome: a case report and review of the literature. Angiology. 2008;59(5):629–31.CrossRef
6.
go back to reference Lin CS, Chen CH, Ding PY. Apical hypertrophic cardiomyopathy mimicking acute myocardial infarction. Int J Cardiol. 1998;64(3):305–7.CrossRef Lin CS, Chen CH, Ding PY. Apical hypertrophic cardiomyopathy mimicking acute myocardial infarction. Int J Cardiol. 1998;64(3):305–7.CrossRef
7.
go back to reference Sayin T, Kocum T, Kervancioglu C. Apical hypertrophic cardiomyopathy mimics acute coronary syndrome. Int J Cardiol. 2001;80(1):77–9.CrossRef Sayin T, Kocum T, Kervancioglu C. Apical hypertrophic cardiomyopathy mimics acute coronary syndrome. Int J Cardiol. 2001;80(1):77–9.CrossRef
8.
go back to reference Abdin A, Eitel I, de Waha S, et al. Apical hypertrophic cardiomyopathy presenting as acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2016;5(3):289–91.CrossRef Abdin A, Eitel I, de Waha S, et al. Apical hypertrophic cardiomyopathy presenting as acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2016;5(3):289–91.CrossRef
9.
go back to reference Morales J, Giraldo M. Case report: apical variant hypertrophic cardiomyopathy simulating an acute inferior myocardial infarction. J Electrocardiol. 2019;52:35–7.CrossRef Morales J, Giraldo M. Case report: apical variant hypertrophic cardiomyopathy simulating an acute inferior myocardial infarction. J Electrocardiol. 2019;52:35–7.CrossRef
10.
go back to reference Lakshmanadoss U, Kulkarni A, Balakrishnan S, et al. All that glitters is not gold: apical hypertrophic cardiomyopathy mimicking acute coronary syndrome. Cardiol Res. 2012;3(3):137–9.PubMedPubMedCentral Lakshmanadoss U, Kulkarni A, Balakrishnan S, et al. All that glitters is not gold: apical hypertrophic cardiomyopathy mimicking acute coronary syndrome. Cardiol Res. 2012;3(3):137–9.PubMedPubMedCentral
11.
go back to reference Rogers PJ, Geib AJ, Cuthbert D, et al. Apical hypertrophic cardiomyopathy: a concerning electrocardiogram in the emergency department. J Emerg Med. 2018;54(6):867–70.CrossRef Rogers PJ, Geib AJ, Cuthbert D, et al. Apical hypertrophic cardiomyopathy: a concerning electrocardiogram in the emergency department. J Emerg Med. 2018;54(6):867–70.CrossRef
12.
go back to reference Chillik I, Ramírez AG, Ordóñez S, et al. Electrocardiographic differences between apical hypertrophic cardiomyopathy and apical non-ST segment myocardial infarction. Medicina (B Aires). 2018;78(2):71–5. Chillik I, Ramírez AG, Ordóñez S, et al. Electrocardiographic differences between apical hypertrophic cardiomyopathy and apical non-ST segment myocardial infarction. Medicina (B Aires). 2018;78(2):71–5.
13.
go back to reference Parr CJ, Sharma R, Garber PJ. Apical hypertrophic cardiomyopathy treated as ST-elevation myocardial infarction. CJEM. 2018;20(S2):S51–S5.CrossRef Parr CJ, Sharma R, Garber PJ. Apical hypertrophic cardiomyopathy treated as ST-elevation myocardial infarction. CJEM. 2018;20(S2):S51–S5.CrossRef
14.
go back to reference Hughes RK, Knott KD, Malcolmson J, et al. Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294.CrossRef Hughes RK, Knott KD, Malcolmson J, et al. Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294.CrossRef
15.
go back to reference Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638–45.CrossRef Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638–45.CrossRef
16.
go back to reference Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the Management of Patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.CrossRef Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the Management of Patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.CrossRef
17.
go back to reference Hannan PJ, Crow RS. Concerning the units for the QT interval corrected by Bazett's formula. Circulation. 1997;96(10):3799.PubMed Hannan PJ, Crow RS. Concerning the units for the QT interval corrected by Bazett's formula. Circulation. 1997;96(10):3799.PubMed
18.
go back to reference Cokkinos DV, Papantonakos A, Perrakis C, et al. The influence of R-wave amplitude on the degree of ST-segment depression in exercise electrocardiography in the individual patient. Angiology. 1987;38(1):22–7.CrossRef Cokkinos DV, Papantonakos A, Perrakis C, et al. The influence of R-wave amplitude on the degree of ST-segment depression in exercise electrocardiography in the individual patient. Angiology. 1987;38(1):22–7.CrossRef
19.
go back to reference Khanna S, Sreedharan R, Maheshwari K, et al. Giant T-wave inversions in apical hypertrophic cardiomyopathy. Anesthesiology. 2019;131(2):398–9.CrossRef Khanna S, Sreedharan R, Maheshwari K, et al. Giant T-wave inversions in apical hypertrophic cardiomyopathy. Anesthesiology. 2019;131(2):398–9.CrossRef
20.
go back to reference Sakamoto T, Tei C, Murayama M, et al. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976;17(5):611–29.CrossRef Sakamoto T, Tei C, Murayama M, et al. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976;17(5):611–29.CrossRef
21.
go back to reference Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003;92(10):1183–6.CrossRef Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003;92(10):1183–6.CrossRef
22.
go back to reference Towe EC, Bos JM, Ommen SR, et al. Genotype-phenotype correlations in apical variant hypertrophic cardiomyopathy: genotype-phenotype correlations in apical HCM. Congenit Heart Dis. 2015;10(3):E139–E45.CrossRef Towe EC, Bos JM, Ommen SR, et al. Genotype-phenotype correlations in apical variant hypertrophic cardiomyopathy: genotype-phenotype correlations in apical HCM. Congenit Heart Dis. 2015;10(3):E139–E45.CrossRef
23.
go back to reference Arad M, Penas-Lado M, Monserrat L, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005;112(18):2805–11.CrossRef Arad M, Penas-Lado M, Monserrat L, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005;112(18):2805–11.CrossRef
24.
go back to reference Duygu H, Zoghi M, Nalbantgil S, et al. Apical hypertrophic cardiomyopathy might lead to misdiagnosis of ischaemic heart disease. Int J Cardiovasc Imaging. 2008;24(7):675–81.CrossRef Duygu H, Zoghi M, Nalbantgil S, et al. Apical hypertrophic cardiomyopathy might lead to misdiagnosis of ischaemic heart disease. Int J Cardiovasc Imaging. 2008;24(7):675–81.CrossRef
25.
go back to reference Meghrajani V, Wats K, Saxena A, et al. A 66-year-old female with apical hypertrophic cardiomyopathy presenting with hypertensive crises and type 2 myocardial infarction and a Normal coronary angiogram. Case Rep Cardiol. 2018;2018:7089149.PubMedPubMedCentral Meghrajani V, Wats K, Saxena A, et al. A 66-year-old female with apical hypertrophic cardiomyopathy presenting with hypertensive crises and type 2 myocardial infarction and a Normal coronary angiogram. Case Rep Cardiol. 2018;2018:7089149.PubMedPubMedCentral
26.
go back to reference Harari R, Smietana J, Madias JE. Progression of electrocardiographic changes in a patient with apical hypertrophic cardiomyopathy. J Electrocardiol. 2019;57:132–4.CrossRef Harari R, Smietana J, Madias JE. Progression of electrocardiographic changes in a patient with apical hypertrophic cardiomyopathy. J Electrocardiol. 2019;57:132–4.CrossRef
27.
go back to reference Madias JE. Electrocardiogram in apical hypertrophic cardiomyopathy with a speculation as to the mechanism of its features. Neth Heart J. 2013;21(6):268–71.CrossRef Madias JE. Electrocardiogram in apical hypertrophic cardiomyopathy with a speculation as to the mechanism of its features. Neth Heart J. 2013;21(6):268–71.CrossRef
28.
go back to reference Vaidya GN, Antoine S, Imam SH, et al. Reciprocal ST-segment changes in myocardial infarction: ischemia at distance versus Mirror reflection of ST-elevation. Am J Med Sci. 2018;355(2):162–7.CrossRef Vaidya GN, Antoine S, Imam SH, et al. Reciprocal ST-segment changes in myocardial infarction: ischemia at distance versus Mirror reflection of ST-elevation. Am J Med Sci. 2018;355(2):162–7.CrossRef
Metadata
Title
Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome
Authors
Yirao Tao
Jing Xu
Samira Yerima Bako
Xiaobo Yao
Donghui Yang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01592-0

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue